Ads
related to: advanced renal cell carcinoma- How This Treatment Works
Learn More About How This
FDA-Approved Treatment Works.
- FAQs
Find FAQs For This Treatment
Option On The Official Patient Site
- Clinical Trial Info
Review Clinical Trial Results For
This FDA-Approved Treatment Option.
- Dosing Information
Get Dosing And Treatment
Schedule Information.
- How This Treatment Works
Search results
David Braun, MD, PhD, on Biomarkers in Renal Cell Carcinoma
MedPage Today· 2 days agoFor patients with metastatic renal cell carcinoma (RCC), there are as yet no reliable biomarkers to...
BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
Clinical Trials Arena via Yahoo Finance· 2 days agoThe company has also developed a subcutaneous version of Opdivo, which was found to be non-inferior...
Leads Biolabs is Proud to Announce its Participation in the 2024 ASCO Annual Meeting with One Oral...
FOX 4 Kansas City· 2 days agoThe 2024 American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago from...
HUTCHMED begins trial of combination therapy for pancreatic ductal adenocarcinoma
Clinical Trials Arena via Yahoo Finance· 21 hours agoIn December last year, Hutchmed finished enrolling subjects in a Phase II/III clinical trial of...
Allogene Therapeutics Inc (ALLO) (Q1 2024) Earnings Call Transcr
Guru Focus· 2 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Allogene Therapeutics Inc (ALLO, Financial) has expanded its market opportunity in large ...
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks via Yahoo Finance· 5 days agoIovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for...
YOUR HEALTH: Why some kidney cancer patients are living longer
WAFB Baton Rouge· 7 days agoKidney cancer is among the 10 most common cancers in both men and women. A decade ago, advanced...
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
Motley Fool via Yahoo Finance· 3 days agoIts two most important markets are renal cell carcinoma (RCC, a type of kidney cancer) and...
AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 7 days agoIn Q1 2024, no additional molecules advanced into the clinic, and we maintained the cumulative total...
Just Say No to Drugs: 3 Pharma Stocks to Avoid
InvestorPlace via Yahoo Finance· 7 days agoFrom its stellar performance in 2021 to deflating in 2022, the biotech sector continued its stagnation into 2023, highlighting some pharma stocks to...